Our Team
Our Board
Jody Aufrichtig
Chief Executive Officer
Jody is an award-winning entrepreneur, business builder, impact investor, and philanthropist. A Chartered Accountant by training, he has built significant and rapid shareholder value in 19 businesses in a broad range of sectors including cannabis, private equity, travel and tourism, sport and leisure, as well as other industries. Jody previously headed up Canopy Growth’s African operations.
Seth Feuerstein
Board Member
Dr. Feuerstein has expertise across multiple areas of medicine. He is Faculty at Yale School of Medicine in the Department of Psychiatry. He is a founding board member of the Center for Biomedical and Interventional Technology at Yale and Executive Director of the Center for Digital Health, Innovation and Excellence. He teaches at the medical school and is the faculty advisor for Innovation in Healthcare at the Yale School of Medicine.
He works across multiple sectors in healthcare including health insurance, healthcare startups, healthcare investing, clinical care delivery innovation and early stage emerging medical technologies. He has serial successes for novel reimbursement in healthcare and is a Former C suite executive at a national health insurer.
Marc Balkin
Board Member
Experienced Non Executive Director with a demonstrated history of working in the management consulting industry. Skilled in Emerging Markets, Entrepreneurship, Venture Capital, Private Equity, and Start-ups. Strong business development professional graduated from University of the Witwatersrand. Partner Di-Game and Former Partner Hasso Plattner Ventures. Mark has served on the investment committees of Enablis, First National Bank Vumela FutureMaker and Alithea IDF. He is also a Newcourt Board Member
Warwick Corden-Lloyd
Chief Financial Officer
Warwick is a Chartered Accountant and Certified Project Manager with over 17 years of work experience in the United Kingdom, the USA, and South Africa. Warwick brings a wide scope of experience ranging from advising the boards of publicly traded companies to strategy design for start-ups. Warwick served as VP Operations and Finance for Canopy Growth Africa and prior to that was the Head of Financial Accounting for Capitec Bank. He is also a CA charter holder from The South African Institute of Chartered Accountants and a member of The Institute of Chartered Accountants in England and Wales.
Scientific Advisory Board
Dr. Clive Ward-Able
Medical Director
Dr Clive Ward-Able is a physician and a pharmacist who has worked in the pharmaceutical industry for over 30 years with 23 of those at the executive level. He has worked in large and small pharmaceutical and biotechnology companies in Canada, US, UK, Switzerland and South Africa in the departments of R&D, medical affairs, marketing and sales.
His experience relates mostly to the medical aspect of therapeutic drug commercialization and has been involved with the launch of over 16 products in multiple therapeutic areas. He is the President of his consultant company, Clintell Inc, and has been acting as consultant Medical Director for numerous start-up companies for the past 4 years. He is currently a member of the Board of Directors for Clinical Trials Ontario.
Seth Feuerstein
Board Member
Dr. Feuerstein has expertise across multiple areas of medicine. He is Faculty at Yale School of Medicine in the Department of Psychiatry. He is a founding board member of the Center for Biomedical and Interventional Technology at Yale and Executive Director of the Center for Digital Health, Innovation and Excellence. He teaches at the medical school and is the faculty advisor for Innovation in Healthcare at the Yale School of Medicine.
He works across multiple sectors in healthcare including health insurance, healthcare startups, healthcare investing, clinical care delivery innovation and early stage emerging medical technologies. He has serial successes for novel reimbursement in healthcare and is a Former C suite executive at a national health insurer.
Dr Dan Stein
Professor and Chair of the Dept of Psychiatry and Mental Health at the University of Cape Town (UCT)
Director of the South African Medical Research Council (MRC) Unit on Risk & Resilience in Mental Disorders.
Dr. Dan J. Stein is internationally recognized as an expert in psychopharmacology. He completed his fellowship and residency training at Columbia University and the New York State Psychiatric Institute. He is a clinician-scientist whose work has long focused on anxiety and related disorders, including obsessive-compulsive spectrum conditions and posttraumatic stress disorder. He has also mentored a range of other research, with publications spanning basic neuroscience, through clinical research, and on to public mental health. Awards for his work include the International College of Neuropsychopharmacologicum’s Max Hamilton Award for his contributions to psychopharmacology, and its Ethics in Psychopharmacology Award.
Our Management Team
Jody Aufrichtig
Chief Executive Officer
Jody is an award-winning entrepreneur, business builder, impact investor, and philanthropist. A Chartered Accountant by training, he has built significant and rapid shareholder value in 19 businesses in a broad range of sectors including cannabis, private equity, travel and tourism, sport and leisure, as well as other industries. Jody previously headed up Canopy Growth’s African operations.
Dr. Neil Maresky
Global Head Clinical Development
Dr. Neil Maresky is the Chief Executive Officer of Psyence Group. Prior to this he was the Vice President Scientific Affairs AstraZeneca, Canada Inc. In addition to 17 years of experience in research-based pharmaceuticals, where he held positions with Wyeth, Bayer, and Novartis, including serving as Director of Drug Safety and Pharmaco-epidemiology, he has worked as a family physician, with experience in cardiology and emergency room care. Dr. Maresky has published in journals that include Human Vaccines, The Canadian Journal of Clinical Pharmacology.
He co-founded and built a charitable foundation that assists underprivileged families with overwhelming medical costs.
Taryn Vos
General Counsel
Taryn is a commercial and corporate attorney and oversees all legal and commercial administrative agreements for the company. She was previously Head of Legal, for Canopy Growth Africa. After working as an associate at Cliffe Dekker Hofmeyr, in Cape Town, she joined Solar Capital, a renewable energy company, as in-house legal counsel. Taryn has also served as legal advisor to Phelan Energy Group, Ltd.
Warwick Corden-Lloyd
Chief Financial Officer
Warwick is a Chartered Accountant and Certified Project Manager with over 17 years of work experience in the United Kingdom, the USA, and South Africa. Warwick brings a wide scope of experience ranging from advising the boards of publicly traded companies to strategy design for start-ups. Warwick served as VP Operations and Finance for Canopy Growth Africa and prior to that was the Head of Financial Accounting for Capitec Bank. He is also a CA charter holder from The South African Institute of Chartered Accountants and a member of The Institute of Chartered Accountants in England and Wales.
Dr. Clive Ward-Able
Medical Director
Dr Clive Ward-Able is a physician and a pharmacist who has worked in the pharmaceutical industry for over 30 years with 23 of those at the executive level. He has worked in large and small pharmaceutical and biotechnology companies in Canada, US, UK, Switzerland and South Africa in the departments of R&D, medical affairs, marketing and sales.
His experience relates mostly to the medical aspect of therapeutic drug commercialization and has been involved with the launch of over 16 products in multiple therapeutic areas. He is the President of his consultant company, Clintell Inc, and has been acting as consultant Medical Director for numerous start-up companies for the past 4 years. He is currently a member of the Board of Directors for Clinical Trials Ontario.